p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 526-529

  Hunt, Jennifer L ^a   LiVolsi, Virginia A ^b   Leon Barnes, E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

p63; Sclerosing mucoepidermoid carcinoma with eosinophilia; SMECE; Solid cell nest; Thyroid; Ultimobranchial body rest

Indexed keywords

CALCITONIN; MUCICARMINE; PROTEIN P63; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL HYPERPLASIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLEROSING MUCOEPIDERMOID CARCINOMA; SQUAMOUS CELL CARCINOMA; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID PARAFOLLICULAR CELL; THYROID TUMOR; ULTIMOBRANCHIAL BODY;

ADULT; CARCINOMA, MUCOEPIDERMOID; DNA-BINDING PROTEINS; EOSINOPHILIA; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHOPROTEINS; SCLEROSIS; THYROID GLAND; THYROID NEOPLASMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 3042846933     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800021     Document Type: Article

References (18)

1. Baloch ZW, Solomon AC, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol 2000;13:802-807.
2. Viciana MJ, Galera-Davidson H, Martin-Lacave I, et al. Papillary carcinoma of the thyroid with mucoepidermoid differentiation. Arch Pathol Lab Med 1996;120:397-398.
3. Arezzo A, Patetta R, Ceppa P, et al. Mucoepidermoid carcinoma of the thyroid gland arising from a papillary epithelial neoplasm. Am Surgeon 1998;64:307-311.
4. Reis-Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 2002;9:280-289.
5. Sim SJ, Ro JY, Ordonez NG, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: report of two patients, one with distant metastasis, and review of the literature. Hum Pathol 1997;28: 1091-1096.
6. Reis-Filho JS, Preto A, Soares P, et al. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 2003;16:43-48.
7. Nylander K, Vojtesek B, Nenutil R, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002;198:417-427.
8. Celli J, Duijf P, Hamel BC, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell. 1999;99:143-153.
9. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-718.
10. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316.
11. Levrero M, De Laurenzi V, Costanzo A, et al. The p53/ p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 2000;113:1661-1670.
12. Parsa R, Yang A, McKeon F, et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113: 1099-1105.
13. Pruneri G, Pignataro L, Manzotti M, et al. p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 2002;82:1327-1334.
14. Reis-Filho JS, Milanezi F, Amendoeira I, et al. p63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clin Pathol 2002;55:936-939.
15. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002;26:1161-1168.
16. Sniezek JC, Matheny KE, Burkey BB, et al. Expression of p63 and 14-3-3sigma in normal and hyperdifferentiated mucosa of the upper aerodigestive tract. Otolaryngol-Head Neck Surg 2002;126:598-601.
17. Werling RW, Hwang H, Yaziji H, et al. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 2003;27:82-90.
18. Preto A, Reis-Filho JS, Ricardo S, et al. p63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression. Pathol Res Pract 2002;198:449-454.